📈 Revenue History (16 Quarters)
🧮 CSBR Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For CSBR, the trailing twelve month revenue is $59.4M.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
CSBR's revenue growth rate of 3.97% (based on log-linear regression of 16 quarters) indicates modest positive growth.
Revenue vs Profitability Metrics
Free Cash Flow: $-5.0M →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: $-5.0M →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $-0.08 →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $-1.2M
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
CSBR's P/S ratio of 1.2x means investors pay $1.16 for every $1 of annual revenue. A P/S between 1-3 is typical for mature companies with moderate growth.
Gross Margin: Revenue Quality
Gross margin of 48.00% shows how much of CSBR's revenue remains after direct costs. Gross margins between 40-60% are solid and typical of differentiated businesses.
Summary: CSBR Revenue Trend
CHAMPIONS ONCOLOGY, INC. (CSBR) generated $59.4M in trailing twelve-month revenue, growing at 3.97% annually — positive but below the 10% level Zyberno considers strong growth. CHAMPIONS ONCOLOGY, INC.'s gross margin of 48.00% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics. For complete financial analysis, view the full CSBR stock report on Zyberno.
Frequently Asked Questions
What is CSBR's current revenue?
CHAMPIONS ONCOLOGY, INC.'s trailing twelve month (TTM) revenue is $59.4M, growing at 3.97% annually — positive but below the 10% level Zyberno considers strong growth.
Is CSBR's revenue growing?
CHAMPIONS ONCOLOGY, INC. (CSBR) generated $59.4M in trailing twelve-month revenue, growing at 3.97% annually — positive but below the 10% level Zyberno considers strong growth. CHAMPIONS ONCOLOGY, INC.'s gross margin of 48.00% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics.
What is CSBR's gross margin?
CHAMPIONS ONCOLOGY, INC.'s gross margin of 48.00% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics.
What is CSBR's Price/Sales ratio?
CSBR's P/S ratio is 1.2x, meaning the market values the company at 1.2 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. CSBR's revenue is $59.4M with a net income of $-1.2M, showing a net profit margin of -2.0%.
📊 Full CSBR Stock Report →
See CSBR's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 CSBR Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 CSBR Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 CSBR Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 CSBR Earnings Surprise (SUE) →
See whether CSBR is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 CSBR Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 CSBR Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 CSBR Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 CSBR Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.